Success

Alert

Please select a Day.

Info

GlaxoSmithKline Pharmaceuticals Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs

Have a query? Talk to Experts LIVE

Follow Following

Score

66/100

2,259.50

-62.10 (-2.67%)

As on 27 Mar, 2026 | 03:59

Open Trading A/c

Day Range

2255.10

2330.40

L H

52 Week Range

2220.30

3515.70

L H

Volume

61,215

* BSE Market Depth (27 Mar 2026)

BUY		SELL
QTY	PRICE	PRICE	QTY
2	2258.00	2310.00	9
1	2257.15	2325.90	4
88	2255.05	2375.00	3
100	2252.00	2376.00	21
10	2250.50	2391.00	21
0	Total	Total	0

Bid / Ask

0.00 / 0.00

Compare Stocks Advanced Chart

Score

66/100

2,258.40

-63.20 (-2.72%)

As on 27 Mar, 2026 | 04:01

Open Trading A/c

Day Range

2257.10

2325.90

L H

52 Week Range

2220.00

3515.95

L H

Volume

3,765

* BSE Market Depth (27 Mar 2026)

BUY		SELL
QTY	PRICE	PRICE	QTY
2	2258.00	2310.00	9
1	2257.15	2325.90	4
88	2255.05	2375.00	3
100	2252.00	2376.00	21
10	2250.50	2391.00	21
0	Total	Total	0

Bid / Ask

0.00 / 0.00

Compare Stocks Advanced Chart

GlaxoSmithKline

2,259.50

-62.10(-2.67%)

NSE

#KnowBeforeYouInvest
Forecast

MC Essentials

65% Pass

MC Technicals

This represents current trend.Click here for disclaimer.

Trend

MC Insights

Superior Financial Strength, High Growth Trend Stock Priced at High Valuations

Financials

Ownerships

Industry Comparison

Others

Overview
Chart
Forecast
MC Insights
MC Technicals
Scans
Price & Volume
Seasonality Analysis
News
Forum
Research
Deals
Corp Action
Financials
Shareholding
Financials Shareholding Peers About

Open	2,320.60
Previous Close	2,321.60
Volume	61,215.00
Value (Lacs)	1,383.15
VWAP	2,282.82
Beta	0.86 0.80
Mkt Cap (Rs. Cr.)	38,277

High	2,330.40
Low	2,255.10
UC Limit	2,785.90
LC Limit	1,857.30
52 Week High	3,515.70
52 Week Low	2,220.30
Face Value	10.00

All Time High	3,515.70
All Time Low	110.00
20D Avg Volume	48,882
20D Avg Delivery(%)	57.81
Book Value Per Share	118.26
Dividend Yield	2.39

TTM EPS See historical trend	60.27 (+18.84% YoY)
TTM PE See historical trend	37.49 (Low PE)
P/B See historical trend	19.11 (Average P/B)
Sector PE	39.43

Advanced Chart

Click here to expand

*Delayed by 20 seconds.

Forecast

Share Price Forecast

Earnings Forecast

Actuals Estimates

ANNUALLY

(Rs.)

EPS
Net Profit
Revenue

Valuations

Consensus Recommendations

Buy
Outperform
Hold
Underperform
Sell

Hits/Misses

QUARTERLY (Rs.)

EPS
Net Profit
Revenue

# of Beats

# of Misses

# of Inline

# of Beats

# of Misses

# of Inline

# of Beats

# of Misses

# of Inline

MC Insights

Stock Score

66/100

Superior Financial Strength, High Growth Trend Stock Priced at High Valuations

Get detailed analysis with Moneycontrol Stock Insights.

Price

35.73% away from 52 week high

Financials

Piotroski Score

indicates

Industry Comparison

Market Cap - Above Median

Shareholding Pattern

Promoter holding remains unchanged at 75.00% in Dec 2025 qtr.

MC Technicals

TECHNICAL RATING

This represents current trend.
Click here for disclaimer.

Trend

See Detail

Historical Rating

Moving Averages	--
Technical Indicators	--
Moving Averages Crossovers	--

Pivot levels

Type	R1	R2	R3	PP	S1	S2	S3
Classic	- -	- -	- -	- -	- -	- -	- -
Fibonacci	- -	- -	- -	- -	- -	- -	- -
Camarilla	- -	- -	- -	- -	- -	- -	- -

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels

R1	- -	Pivot - -	S1	- -
R2	- -		S2	- -
R3	- -		S3	- -

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Moving Averages

Days
5	- -
10	- -
20	- -
50	- -
100	- -
200	- -

TECHNICAL RATING

This represents current trend.
Click here for disclaimer.

Trend

See Detail

Historical Rating

Moving Averages	--
Technical Indicators	--
Moving Averages Crossovers	--

Pivot levels

Type	R1	R2	R3	PP	S1	S2	S3
Classic	- -	- -	- -	- -	- -	- -	- -
Fibonacci	- -	- -	- -	- -	- -	- -	- -
Camarilla	- -	- -	- -	- -	- -	- -	- -

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels

R1	- -	Pivot - -	S1	- -
R2	- -		S2	- -
R3	- -		S3	- -

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Moving Averages

Days

TECHNICAL RATING

This represents current trend.
Click here for disclaimer.

Trend

See Detail

Historical Rating

Moving Averages	--
Technical Indicators	--
Moving Averages Crossovers	--

Pivot levels

Type	R1	R2	R3	PP	S1	S2	S3
Classic	- -	- -	- -	- -	- -	- -	- -
Fibonacci	- -	- -	- -	- -	- -	- -	- -
Camarilla	- -	- -	- -	- -	- -	- -	- -

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Pivot levels

R1	- -	Pivot - -	S1	- -
R2	- -		S2	- -
R3	- -		S3	- -

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Moving Averages

Days

Price and Volume

Price Performance

1 Week		--%
1 Month		--%
3 Months		--%
YTD		--%
1 Year		--%
3 Years		--%

Volume Analysis

Volume
Delivery

SEASONALITY ANALYSIS

10 out of 18 years GlaxoSmithKline Pharmaceuticals has given negative returns in March.

Month	Max. Positive Change(%)	Avg. Positive Change(%)	Max. Negative Change(%)	Avg. Negative Change(%)	Average Change(%)
March	20.82% (2016)	9.93%	-15.50% (2014)	-7.48%	0.26%

Seasonality Analysis

News

Stocks to Watch Today: Tata Motors, Andhra Cements, Sun Pharma, GMDC, Axiscades, Power Mech, Zydus Lifesciences, Bajaj Electricals in focus on 17 March

Mar 17 2026 02:25 AM

Glaxosmithkline Pharmaceuticals share price falls 2.02% amid intraday trade Feb 12 2026 12:45 PM
GlaxoSmithKline Standalone December 2025 Net Sales at Rs 1,022.59 crore, up 8.06% Y-o-Y Feb 10 2026 12:33 PM
GlaxoSmithKline Consolidated December 2025 Net Sales at Rs 1,041.26 crore, up 9.67% Y-o-Y Feb 10 2026 12:10 PM
Samir Arorau2013backed Helios Flexi Cap exits Ola Electric, ICICI Lombard, LG Electronics in January rejig Feb 09 2026 11:50 AM

Earning + See More

Forum

Community Sentiments

100% BUY
0% SELL
0% HOLD

100%

of moneycontrol users recommend buying GlaxoSmithKline

What's your call on GlaxoSmithKline today?

Read 0 investor views

BUY SELL HOLD

xra
GlaxoSmithKline
Follow

Buy Forget for four years plus View more

Posted by : xra
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  Buy Forget for four years plus
  
  Repost Cancel
You will now receive notification when someone reply to this message.
kamal20
GlaxoSmithKline
Follow

9 days ago

juby chandy has resigned as whole-time director and chief financial officer cfo of the company, effective march 11, 2026. View more

Posted by : kamal20
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  juby chandy has resigned as whole-time director and chief financial officer cfo of the company, effective march 11, 2026.
  
  Repost Cancel
You will now receive notification when someone reply to this message.
The Fixed Income
Just Posted
Follow

3 days ago

Sponsored Post
Bond maturity allows the investors to determine and pool their investments as per their specific financial timelines such as education funding, retirement needs, or planned expenses. https://www.thefixedincome.com/register?utm_source=moneycontrol&utm_medium=mcforum&utm_campaign=signup_page View more

Posted by : The Fixed Income
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  Bond maturity allows the investors to determine and pool their investments as per their specific financial timelines such as education funding, retirement needs, or planned expenses. https://www.thefixedincome.com/register?utm_source=moneycontrol&utm_medium=mcforum&utm_campaign=signup_page
  
  Repost Cancel
You will now receive notification when someone reply to this message.

+ See More

Broker Research

ICICI Securities

Reco Price -

Target Price 2500

Deven Choksey

Reco Price -

Target Price 2300

02 Aug, 2025

Motilal Oswal

Reco Price 2933.90

Target Price 3000

14 May, 2025

ICICI Securities

Reco Price 2877.10

Target Price 2600

REFINITIV Report

No Data For Block Deals.

*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

No Data For Bulk Deals.

*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

Corporate Action

25 Mar, 2026 | 03:03PM

Closure of Trading Window
As per attachment
24 Mar, 2026 | 12:11PM

Disclosure Under Regulation 30
As per attachment
16 Mar, 2026 | 05:58PM

Announcement under Regulation 30 (LODR)-Change in Management
As per attachment

+ See More

Date	Agenda

+ See More

Ex-Date	Type	Dividend (Rs)

+ See More

Announcement Date	Ex-Bonus	Ratio

+ See More

Ex-Split	Old FV	New FV

+ See More

Ex-Right	Ratio	Premium

+ See More

Date	Agenda

+ See More

Financials

Consolidated
Standalone

Quarterly Annually

(Rs. Cr)

Quarterly
Half Yearly
Nine Months
Annual

Detailed Financials

(Rs. Cr)

Revenue

Net Profit

BVPS

Debt to Equity

Quarterly
Half Yearly
Nine Months
Annual

Detailed Financials

Shareholding

Summary

See Top Holdings

Trend

About the Company

GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company. The GSK India product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases. The company is the market leader in most of the therapeutic categories in which it operates. GSK also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others.

Registered Office
- Address
  GSK House,,Dr. Annie Besant Road,,Worli,
- City
  Mumbai
- State
  Maharashtra
- Pin Code
  400030
- Tel. No.
  022-24959595
- Fax No.
  022-24959494
- Email
  in.investorquery@gsk.com
- Internet
  http://www.gsk-india.com
Registrars
- Address
  Selenium Tower B, Plot No. 31-32,,Gachibowli, Financial District, Nanakramguda,Seri
- City
  Hyderabad 500032
- State
  Telangana
- Tel. No.
  040-67161500, 67162222, 33211000
- Fax No.
  040-23420814, 23001153
- Email
  einward.ris@karvy.com
- Internet
  http://www.kfintech.com
Management
- R S Karnad
  Chairperson
- B Akshikar
  Managing Director
- J Chandy
  WholeTime Director & CFO
- S Williams
  Non Executive Director
- M Anand
  Independent Director
+ See More
Included In
- BSE 100
  No
- BSE 200
  Yes
- SENSEX
  No
- CNX MIDCAP 200
  No
- NIFTY 50
  No
- BSE 500
  Yes
- Nifty 200
  No
Details
- BSE:
  500660
- NSE:
  GLAXO
- Series
  EQ
- ISIN
  INE159A01016